Skip to main content

Baseline chronic kidney disease does not predict long-term renal functional decline after percutaneous nephrolithotomy

Urolithiasis volume 47, pages 449–453 (2019)Cite this article

Abstract

To compare renal functional outcomes in patients with and without chronic kidney disease (CKD) to identify predictors of change in renal function after percutaneous nephrolithotomy (PCNL). We reviewed patients who underwent PCNL by a single surgeon over 3.5 years. Patients’ pre- and post-operative Glomerular Filtration Rate (GFR) was calculated. Baseline GFR < 60 ml/min/1.73 m2 (stage ≥ 3 CKD) defined our CKD cohort. Patients’ baseline renal function, comorbidities, stone parameters, and intra-operative variables were analyzed to determine the relationship with post-operative renal function after PCNL by multivariate analysis. 202 patients were analyzed. Mean follow-up time was 16 months. At baseline, 163 (80.7%) patients were free of CKD and 39 (19.3%) had CKD. Patients without CKD had an overall decrease in GFR from 105.6 to 103.3 ml/min/1.73 m2 (p = 0.494). 14/163 (8.6%) non-CKD patients experienced a significant decline in renal function after PCNL; 7/163 (4.3%) developed de novo CKD and 7 had a ≥ 30% decline in GFR. Patients with CKD had an overall increase in mean GFR post-operatively, from 47.3 to 54.0 ml/min/m2 (p = 0.067). Two in this cohort (5.1%) experienced a > 30% decline in renal function post-operatively. Age, gender, African American race, presence of comorbidities and pre-operative CKD were not significant predictors of renal function post-operatively on multivariate analysis. PCNL in this cohort appears GFR neutral in the setting of baseline CKD. CKD was not predictive of renal functional decline after PCNL. Given that stone disease carries a high recurrence rate and that CKD is associated with stone formers, further investigation into predictors of renal function change after PCNL is warranted.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

References

  1. Litwin M, Saigal C (2012) Economic impact of urologic disease, N.I.o.H. National Institute of Diabetes and Digestive and Kidney Diseases, US Department of Health and Human Services, Editor. 2012: Urologic Diseases in America. NIH Publication 12-7865, Washington, DC, p 486

  2. Alexander RT et al (2012) Kidney stones and kidney function loss: a cohort study. BMJ 345:e5287

    Article  Google Scholar 

  3. Ferraro PM et al (2013) History of kidney stones and the risk of coronary heart disease. JAMA 310(4):408–415

    Article  CAS  Google Scholar 

  4. Melton LJ III et al (1998) Fracture risk among patients with urolithiasis: a population-based cohort study. Kidney Int 53(2):459–464

    Article  Google Scholar 

  5. Edvardsson VO et al (2013) Temporal trends in the incidence of kidney stone disease. Kidney Int 83(1):146–152

    Article  Google Scholar 

  6. Akman T et al (2012) The impact of metabolic syndrome on long-term outcomes of percutaneous nephrolithotomy (PCNL). BJU Int 110(11 Pt C):E1079–E1083

    Article  CAS  Google Scholar 

  7. Bilen CY et al (2008) Impact of percutaneous nephrolithotomy on estimated glomerular filtration rate in patients with chronic kidney disease. J Endourol 22(5):895–900

    Article  Google Scholar 

  8. Shoag J et al (2014) Risk of chronic and end stage kidney disease in patients with nephrolithiasis. J Urol 192(5):1440–1445

    Article  Google Scholar 

  9. El-Zoghby ZM et al (2012) Urolithiasis and the risk of ESRD. Clin J Am Soc Nephrol 7(9):1409–1415

    Article  Google Scholar 

  10. Rule AD et al (2009) Kidney stones and the risk for chronic kidney disease. Clin J Am Soc Nephrol 4(4):804–811

    Article  Google Scholar 

  11. Kurien A et al (2009) The impact of percutaneous nephrolithotomy in patients with chronic kidney disease. J Endourol 23(9):1403–1407

    Article  Google Scholar 

  12. Preminger GA, Lingerman JE, Nakada SY, Pearle MS, Wolf JS (2009) Report on the management of staghorn calculi (2005). Clinical guidelines 2005. https://www.auanet.org/education/guidelines/staghorn-calculi.cfm. Accessed 2015

  13. Ozden E et al (2012) Long-term outcomes of percutaneous nephrolithotomy in patients with chronic kidney disease: a single-center experience. Urology 79(5):990–994

    Article  Google Scholar 

  14. Kuzgunbay B et al (2010) Long-term renal function and stone recurrence after percutaneous nephrolithotomy in patients with renal insufficiency. J Endourol 24(2):305–308

    Article  Google Scholar 

  15. Stevens LA, Viswanathan G, Weiner DE (2010) Chronic kidney disease and end-stage renal disease in the elderly population: current prevalence, future projections, and clinical significance. Adv Chronic Kidney Dis 17(4):293–301

    Article  Google Scholar 

  16. Ordon M et al (2015) A population based study of the changing demographics of patients undergoing definitive treatment for kidney stone disease. J Urol 193(3):869–874

    Article  Google Scholar 

  17. Eknoyan G (2003) Meeting the challenges of the new K/DOQI guidelines. Am J Kidney Dis 41(5 Suppl):3–10

    Article  Google Scholar 

  18. Levey AS, Coresh J (2012) Chronic kidney disease. Lancet 379(9811):165–180

    Article  Google Scholar 

  19. Drew DA et al (2017) Association between soluble Klotho and change in kidney function: the health aging and body composition study. J Am Soc Nephrol 28(6):1859–1866

    Article  Google Scholar 

  20. Go AS et al (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351(13):1296–1305

    Article  CAS  Google Scholar 

  21. Sigurjonsdottir VK et al (2015) Impact of nephrolithiasis on kidney function. BMC Nephrol 16:149

    Article  CAS  Google Scholar 

  22. Sairam K et al (2012) Percutaneous nephrolithotomy and chronic kidney disease: results from the CROES PCNL global study. J Urol 188(4):1195–1200

    Article  Google Scholar 

  23. Collins AJ et al (2011) US renal data system 2010 annual data report. Am J Kidney Dis 57(1 Suppl 1):A8 (e1–526)

    Google Scholar 

  24. Wuerzner G et al (2010) Marked association between obesity and glomerular hyperfiltration: a cross-sectional study in an African population. Am J Kidney Dis 56(2):303–312

    Article  Google Scholar 

  25. Hsu CY et al (2009) Risk factors for end-stage renal disease: 25-year follow-up. Arch Intern Med 169(4):342–350

    Article  Google Scholar 

  26. Rosenberg M, Hsu CY (2004) Chronic kidney disease and progression. NephSAP 3(6):304–308

    Google Scholar 

  27. Derose SF et al (2013) Racial differences in estimated GFR decline, ESRD, and mortality in an integrated health system. Am J Kidney Dis 62(2):236–244

    Article  Google Scholar 

  28. Nouralizadeh A, Sichani MM, Kashi AH (2011) Impacts of percutaneous nephrolithotomy on the estimated glomerular filtration rate during the first few days after surgery. Urol Res 39(2):129–133

    Article  Google Scholar 

  29. Handa RK et al (2010) Time-course for recovery of renal function after unilateral (single-tract) percutaneous access in the pig. J Endourol 24(2):283–288

    Article  Google Scholar 

  30. Perez-Fentes D et al (2014) Does percutaneous nephrolithotomy and its outcomes have an impact on renal function? Quantitative analysis using SPECT-CT DMSA. Urolithiasis 42(5):461–7

    Article  CAS  Google Scholar 

  31. Handa RK et al (2015) Percutaneous renal access: surgical factors involved in the reduction of renal function. J Endourol 30(2):178–183

    Article  Google Scholar 

Download references

Funding

None.

Author information

Affiliations

  1. Department of Urology, Montefiore Medical Center, Bronx, USA

    Kara L. Watts, Abhishek Srivastava & Joshua M. Stern

  2. Albert Einstein College of Medicine, Bronx, USA

    Kara L. Watts, Wilson Lin, Daniel Schoenfeld & Joshua M. Stern

  3. Department of Medicine (Nephrology), Montefiore Medical Center, 1300 Morris Park Ave., Bronx, NY, 10461, USA

    Matthew Abramowitz

  4. 3400 Bainbridge Ave., Bronx, NY, 10467, USA

    Kara L. Watts & Abhishek Srivastava

  5. 1935 Eastchester Road #15F, Bronx, NY, 10461, USA

    Wilson Lin

  6. 1945 Eastchester Road # 5G, Bronx, NY, 10461, USA

    Daniel Schoenfeld

  7. 1250 Waters Place, Tower 1, Suite 706, Bronx, NY, 10461, USA

    Joshua M. Stern

Authors
  1. Kara L. Watts
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Abhishek Srivastava
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Wilson Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Daniel Schoenfeld
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Matthew Abramowitz
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Joshua M. Stern
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kara L. Watts.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Watts, K.L., Srivastava, A., Lin, W. et al. Baseline chronic kidney disease does not predict long-term renal functional decline after percutaneous nephrolithotomy. Urolithiasis 47, 449–453 (2019). https://doi.org/10.1007/s00240-019-01113-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00240-019-01113-5

Keywords

  • PCNL
  • CKD
  • Renal function
  • Kidney stone